Strive Health Adds Chief Technology Officer and Chief Actuary to Leadership Team
'Tom and Amit bring valuable experience in healthcare technology, actuarial science and value-based care to our team,' said Chris Riopelle, Co-Founder and CEO of Strive. 'Their backgrounds are a great match for Strive's goals as we grow and work to improve outcomes for both our patients and customers.'
Tom Hawkes Hired as Chief Technology Officer
Hawkes is an experienced healthcare leader with nearly 20 years of expertise across the value-based care spectrum. As Chief Technology Officer, he will oversee Strive's technology strategy, innovation roadmap and IT infrastructure to support care delivery and business operations.
His previous roles include serving as the Chief Information Officer and Chief Product Officer at Caravan Health and Senior Vice President of Product at Signify Health, where Hawkes supported over 200 health systems and 1 million patients in Medicare Shared Savings Programs and Accountable Care Organizations. He played a key role in the acquisition of Caravan Health by Signify Health and the subsequent sale of Signify to CVS Health. Hawkes' experience also includes leadership positions at Kaiser Permanente, the Hawaii Permanente Medical Group, The Queen's Health System and Queen's Clinically Integrated Physician Network.
'I'm excited to join Strive at this pivotal moment in healthcare transformation,' Hawkes said. 'I look forward to helping the team leverage technology to improve patient outcomes, reduce inefficiencies and advance value-based care.'
Amit Trivedi Joins as Chief Actuary
Trivedi brings nearly 30 years of experience in actuarial science, underwriting and medical economics — with expertise in Medicare Advantage, value-based contracts and population health strategy. As Chief Actuary, he will lead Strive's actuarial team, overseeing pricing, risk management and financial modeling to support the organization's value-based care programs and sustainable growth.
Prior to joining Strive, Trivedi served as Chief Actuary at several prominent healthcare organizations, including Beacon Health Options, Prospero Health, Landmark Health and Tomorrow Health. His background also includes leadership roles at Evolent Health and Oliver Wyman.
'Joining Strive represents an opportunity to apply actuarial science in innovative ways that positively impact healthcare outcomes,' Trivedi said. 'I look forward to working with this talented team to develop robust risk management strategies and pricing models that support sustainable growth so Strive can continue to transform kidney care for the better.'
ABOUT STRIVE HEALTH
Strive Health is the nation's leader in value-based kidney care and partner of choice for innovative healthcare payors and providers. Using a unique combination of technology-enabled care interventions and seamless integration with local providers, Strive forms an integrated care delivery system that supports the entire patient journey from chronic kidney disease (CKD) to end-stage kidney disease (ESKD). To help patients, Strive partners with commercial and Medicare Advantage payors, Medicare, health systems and physicians through flexible value-based payment arrangements, including risk-based programs. Strive serves over 130,000 people with CKD and ESKD across 50 states and partners with over 6,500 providers. Strive's case management and population health programs are accredited by the National Committee for Quality Assurance (NCQA), and its technology platform, CareMultiplier™, is certified by HITRUST. To learn more, visit StriveHealth.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 hours ago
- Yahoo
Clover Health Investments Corp (CLOV) Q2 2025 Earnings Call Highlights: Surpassing Growth ...
Release Date: August 05, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Clover Health Investments Corp (NASDAQ:CLOV) reported significant membership growth of over 30% year-over-year, surpassing industry averages. The company achieved sustained adjusted profitability in Medicare Advantage, demonstrating effective execution of its strategy. Clover Health's technology-first care model, including the Clover Assistant, has shown to improve health outcomes, such as reducing hospitalizations and readmissions for chronic diseases. The company is well-positioned for future growth with a four-star payment year in 2026, providing a financial tailwind. Clover Health is expanding its technology platform to other risk-bearing entities, showing broad interest and uptake, which could drive additional revenue streams. Negative Points Clover Health is experiencing elevated cost trends within its Medicare Advantage book, similar to broader industry pressures. The company is facing variability in modeling performance due to the new Part D IRA changes, which could impact financial results. There are elevated pockets of utilization within supplemental benefits and Part B, which negatively impacted results. The competitive landscape remains challenging, with national players pulling back in certain areas, potentially affecting market dynamics. Clover Health's insurance benefit expense ratio (BER) increased year-over-year, reflecting higher costs and impacting profitability. Q & A Highlights Warning! GuruFocus has detected 4 Warning Signs with CLOV. Q: The MCR BER came in above expectations. How much conservatism is embedded in your raised guidance on the BER, and how much visibility do you have into how that trend will develop in the back half of the year? A: The increase in the BER guidance for the full year is mostly related to Part D and supplemental benefits, particularly dental. We have initiatives in place to monitor this going forward, and we believe there will be some relief on the Part D pressure from the IRA as we move into 2026. - Peter Kuipers, CFO Q: What are the drivers for the improvements in your SG&A or adjusted SG&A? Are you holding back on hiring or finding new efficiencies within the model? A: The improvements are mostly due to cost efficiencies. We initiated a company-wide cost initiative to rationalize the price and volume terms with our partnership contracts. As we are growing above the industry, we are renegotiating terms with partners to reflect our effective partnership. - Peter Kuipers, CFO Q: What kind of response have you been getting from the COPD white paper, and are there plans to publish similar papers? A: We are proud of the papers we are publishing, including the recent COPD white paper. We plan to continue producing such material as it highlights the benefits of using Clover Assistant, which is correlated with better diagnosis management and care. These results are also used to promote our offerings in the counterpart context. - Andrew Toy, CEO Q: Is the elevated cost trend you're seeing more localized to newer cohorts, or is it broad-based? Are there any geographical differences? A: The cohorts in our tech-first model are performing as expected. We do not see a specific split between new and returning members regarding Part D and supplemental benefits. Returning members are improving from an MCR and BER perspective as expected. - Peter Kuipers, CFO Q: How are competitors approaching the upcoming AP, and are there any differences in the competitive landscape compared to last year? A: Many national players are pulling back, especially in the PPO wider network where they struggle to deploy their managed care capabilities. This is an area where we are strong due to our technology. We feel well-placed for the coming growth season, especially with the financial tailwind of a four-star payment year in 2026. - Andrew Toy, CEO For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Sign in to access your portfolio
Business Wire
a day ago
- Business Wire
A10 Networks Reports Financial Results for the Second Quarter of 2025
SAN JOSE, Calif.--(BUSINESS WIRE)--A10 Networks, Inc. (NYSE: ATEN), a leading provider of secure application services and solutions, today announced financial results for its second quarter ended June 30, 2025. Second Quarter 2025 Financial Summary Revenue of $69.4 million, up 15% year-over-year compared to $60.1 million in the second quarter of 2024. Revenue for the first six months of 2025 was $135.5 million compared to $120.8 million for the first six months of 2024, an increase of approximately 12%. GAAP gross margin of 78.9%; non-GAAP gross margin of 80.0%. GAAP net income of $10.5 million (15.2% of revenue), or $0.14 per diluted share, compared to net income of $9.5 million (15.8% of revenue), or $0.13 per diluted share, in the second quarter of 2024. Non-GAAP net income of $15.5 million (22.3% of revenue), or $0.21 per diluted share, compared to non-GAAP net income of $13.2 million (22.0% of revenue), or $0.18 per diluted share in the second quarter of 2024. The Company returned $8.3 million to investors, having repurchased 229 thousand shares at an average price of $17.22 for a total of $3.9 million and having paid $4.3 million in cash dividends in the quarter. The Company has $71.1 million remaining on its $75.0 million share repurchase authorization. The Board of Directors approved a quarterly cash dividend of $0.06 per share, payable September 2, 2025 to stockholders of record at the close of business on August 15, 2025. A reconciliation between GAAP and non-GAAP information is contained in the financial statements below. 'Demand for our security and infrastructure solutions continues to grow as end markets normalized compared to same period last year, driving year-over-year revenue growth,' said Dhrupad Trivedi, President and Chief Executive Officer of A10 Networks. 'The second quarter benefited from improving demand from data center expansions and AI infrastructure investments. This includes the recent selection of A10 by global leaders in AI data centers, which serves as an important validation of our security-led innovation and growing relevance in AI-centric environments.' 'A10 maintains strong operational discipline, effectively translating revenue growth into improved profitability and cash flow,' continued Trivedi. 'We achieved expansion in both GAAP and non-GAAP net margins, grew earnings per share, and delivered robust cash flow from operations. We expect operating leverage to remain a key advantage moving forward.' 'The strength of our business model and customer intimacy, combined with favorable market dynamics in AI and cybersecurity, positions A10 to deliver long-term value as we continue to navigate evolving market conditions,' said Trivedi. 'We remain focused on disciplined execution to drive sustained top- and bottom-line growth.' Conference Call Management will host a call at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) today, August 5, 2025, to discuss these results. Interested parties may access the conference call by dialing (888) 506-0062 (toll-free) or (973) 528-0011 (international) and referencing access code: 117352. A live audio webcast of the conference call will be accessible from the 'Investor Relations' section of A10 Network's website at The webcast will be archived for one year. A telephonic replay of the conference call will be available until August 19, 2025 and may be accessed by dialing (877) 481-4010 (toll-free) or (919) 882-2331 (international) and entering the passcode: 52680. Forward-Looking Statements This press release contains 'forward-looking statements,' including statements regarding our quarterly dividend payments, strategy, positioning, demand, growth rate, margin profile, operating leverage, profitability and return of capital. Forward-looking statements are subject to known and unknown risks and uncertainties and are based on assumptions that may prove to be incorrect, which could cause actual results to differ materially from those expected or implied by the forward-looking statements. Factors that may cause actual results to differ include any unforeseen need for capital which may require us to divert funds we may have otherwise used for the dividend program or stock repurchase program, which may in turn negatively impact our ability to administer the quarterly dividends or the repurchase of our common stock; a significant decline in global macroeconomic or political conditions that have an adverse impact on our business and financial results; an expansion of adversarial global trade dynamics or other changes to international trade regulations; business interruptions related to our supply chain; our ability to manage our business and expenses if customers cancel or delay orders; execution risks related to closing key deals and improving our execution; the continued market adoption of our products; our ability to successfully anticipate market needs and opportunities; our timely development of new products and features; our ability to achieve or maintain profitability; any loss or delay of expected purchases by our largest end-customers; our ability to maintain or improve our competitive position; competitive and execution risks related to cloud-based computing trends; our ability to attract and retain new end-customers and our largest end-consumers; our ability to maintain and enhance our brand and reputation; changes demanded by our customers in the deployment and payment model for our products; continued growth in markets relating to network security; the success of any future acquisitions or investments in complementary companies, products, services or technologies; the ability of our sales team to execute well; our ability to shorten our close cycles; the ability of our channel partners to sell our products; variations in product mix or geographic locations of our sales; risks associated with our presence in international markets; weaknesses or deficiencies in our internal control over financial reporting; our ability to timely file periodic reports required to be filed under the Securities Exchange Act of 1934; and other risks that are described in 'Risk Factors' in our periodic filings with the Securities and Exchange Commission, including our Form 10-K filed with the Securities and Exchange Commission on February 25, 2025. We do not intend to update or alter our forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. Non-GAAP Financial Measures In addition to disclosing financial measures prepared in accordance with U.S. generally accepted accounting principles (GAAP), we refer to certain non-GAAP financial measures, including non-GAAP net income, non-GAAP net income per basic and diluted share (or non-GAAP EPS), non-GAAP gross profit and gross margin, non-GAAP operating expenses, non-GAAP operating income and operating margin, Adjusted EBITDA and Adjusted EBITDA margin. Non-GAAP financial measures do not have any standardized meaning and are therefore unlikely to be comparable to similarly titled measures presented by other companies. A10 Networks considers these non-GAAP financial measures to be important because they provide useful measures of the operating performance of the company, exclusive of unusual events or factors that do not directly affect what we consider to be our core operating performance and are used by the company's management for that purpose. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. We define non-GAAP net income as our GAAP net income excluding: (i) stock-based compensation and related payroll tax, (ii) acquisition-related expense, (iii) amortization of purchased intangible assets, (iv) one-time legal expense, (v) tax planning expense and (vi) income tax effect of non-GAAP items (i) to (v) listed above. We define non-GAAP net income per basic and diluted share as our non-GAAP net income divided by our basic and diluted weighted-average shares outstanding. We define non-GAAP gross profit as our GAAP gross profit excluding (i) stock-based compensation and related payroll tax and (ii) amortization of purchased intangible assets. We define non-GAAP gross margin as our non-GAAP gross profit divided by our GAAP revenue. We define non-GAAP operating expenses as our GAAP operating expenses excluding (i) stock-based compensation and related payroll tax, (ii) acquisition-related expense, (iii) amortization of purchased intangible assets, (iv) one-time legal expense and (v) tax planning expense. We define non-GAAP operating income as our GAAP income from operations excluding (i) stock-based compensation and related payroll tax, (ii) acquisition-related expense, (iii) amortization of purchased intangible assets, (iv) one-time legal expense and (v) tax planning expense. We define non-GAAP operating margin as our non-GAAP operating income divided by our GAAP revenue. We define Adjusted EBITDA as our GAAP net income excluding (i) interest and other (income) expense, net, (ii) depreciation and amortization expense, (iii) provision for income taxes, (iv) stock-based compensation and related payroll tax, (v) acquisition-related expense, (vi) one-time legal expense and (vii) tax planning expense. We define Adjusted EBITDA margin as our Adjusted EBITDA divided by our GAAP revenue. Non-GAAP financial measures are presented for supplemental informational purposes only for understanding the company's operating results. About A10 Networks A10 Networks (NYSE: ATEN) provides security and infrastructure solutions for on-premises, hybrid cloud, and edge-cloud environments. Our 7,000+ customers span global large enterprises and communications, cloud and web service providers who must ensure business-critical applications and networks are secure, available, and efficient. Founded in 2004, A10 Networks is based in San Jose, Calif. and serves customers globally. For more information, visit and follow us at A10Networks. The A10 logo and A10 Networks are trademarks or registered trademarks of A10 Networks, Inc. in the United States and other countries. All other trademarks are the property of their respective owners. Source: A10 Networks, Inc. Three Months Ended June 30, Six Months Ended June 30, GAAP net income $ 10,538 $ 9,476 $ 20,081 $ 19,202 Non-GAAP items: Stock-based compensation and related payroll tax 4,586 4,309 10,878 8,298 Acquisition-related expense 574 — 918 — Amortization of purchased intangible assets 380 — 583 — One-time legal expense 721 71 1,247 71 Tax planning expense 150 400 150 400 Income tax-effect of non-GAAP items (1,496 ) (1,046 ) (3,369 ) (2,017 ) Total non-GAAP items 4,915 3,734 10,407 6,752 Non-GAAP net income $ 15,453 $ 13,210 $ 30,488 $ 25,954 GAAP net income per share: Basic $ 0.15 $ 0.13 $ 0.28 $ 0.26 Diluted $ 0.14 $ 0.13 $ 0.27 $ 0.25 Non-GAAP items: Stock-based compensation and related payroll tax 0.06 0.05 0.15 0.11 Acquisition-related expense 0.01 — 0.01 — Amortization of purchased intangible assets 0.01 — 0.01 — One-time legal expense 0.01 — 0.02 — Tax planning expense — 0.01 — 0.01 Income tax-effect of non-GAAP items (0.02 ) (0.01 ) (0.05 ) (0.03 ) Total non-GAAP items 0.07 0.05 0.14 0.09 Non-GAAP net income per share: Basic $ 0.21 $ 0.18 $ 0.42 $ 0.35 Diluted $ 0.21 $ 0.18 $ 0.41 $ 0.34 Weighted average shares used in computing net income per share: Basic 72,009 74,366 72,777 74,401 Diluted 73,117 75,497 74,109 75,432 Expand Net income and earnings per share excluding adjustments are non-GAAP financial measures presented as supplemental financial measures to enable a user of the financial information to understand the impact of these adjustments on reported results. These financial measures should not be considered an alternative to net income, operating income, cash flows provided by operating activities, or any other measure of financial performance or liquidity presented in accordance with U.S. GAAP. Our adjusted net income and earnings per share may not be comparable to similarly titled measures of another company because companies may not all calculate adjusted net income and earnings per share in the same manner. As of December 31, 2024 ASSETS Current assets: Cash and cash equivalents $ 252,924 $ 95,129 Marketable securities 114,459 100,429 Accounts receivable, net of allowances of $357 and $465, respectively 52,364 76,687 Inventory 20,082 22,005 Prepaid expenses and other current assets 17,233 13,038 Total current assets 457,062 307,288 Property and equipment, net 44,458 39,142 Goodwill 15,070 1,307 Intangible assets, net 7,018 — Deferred tax assets, net 62,362 62,364 Other non-current assets 21,945 22,714 Total assets $ 607,915 $ 432,815 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 6,999 $ 12,542 Accrued and other liabilities 27,815 32,696 Deferred revenue, current 73,345 78,335 Total current liabilities 108,159 123,573 Deferred revenue, non-current 71,021 69,924 Long-term debt 218,086 — Other non-current liabilities 6,661 7,489 Total liabilities 403,927 200,986 Stockholders' equity: Common stock, $0.00001 par value: 500,000 shares authorized; 91,450 and 90,520 shares issued and 71,992 and 73,693 shares outstanding, respectively 1 1 Treasury stock, at cost: 19,458 and 16,827 shares, respectively (231,965 ) (180,992 ) Additional paid-in-capital 520,524 508,387 Dividends paid (64,172 ) (55,417 ) Accumulated other comprehensive income (loss) (137 ) 194 Accumulated deficit (20,263 ) (40,344 ) Total stockholders' equity 203,988 231,829 Total liabilities and stockholders' equity $ 607,915 $ 432,815 Expand A10 NETWORKS, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited, in thousands, on a GAAP Basis) Six Months Ended June 30, 2025 2024 Cash flows from operating activities: Net income $ 20,081 $ 19,202 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 7,077 5,507 Stock-based compensation 10,427 8,105 Other non-cash items 685 (403 ) Changes in operating assets and liabilities: Accounts receivable 24,031 16,695 Inventory 1,609 (3,318 ) Prepaid expenses and other assets (5,865 ) (541 ) Accounts payable (6,379 ) (2,859 ) Accrued liabilities (5,937 ) 3,640 Deferred revenue (6,345 ) (1,378 ) Net cash provided by operating activities 39,384 44,650 Cash flows from investing activities: Proceeds from sales of marketable securities — 22,536 Proceeds from maturities of marketable securities 54,744 47,699 Purchases of marketable securities (68,148 ) (106,293 ) Acquisition (19,100 ) — Capital expenditures (8,737 ) (6,414 ) Net cash used in investing activities (41,241 ) (42,472 ) Cash flows from financing activities: Proceeds from issuance of common stock under employee equity incentive plans 1,710 1,854 Proceeds from the issuance of convertible notes 225,000 — Payment of debt issuance costs (7,330 ) — Repurchase of common stock (50,973 ) (14,876 ) Payments for dividends (8,755 ) (8,943 ) Net cash provided by (used in) financing activities 159,652 (21,965 ) Net increase (decrease) in cash and cash equivalents 157,795 (19,787 ) Cash and cash equivalents—beginning of period 95,129 97,244 Cash and cash equivalents—end of period $ 252,924 $ 77,457 Non-cash investing and financing activities: Transfers between inventory and property and equipment $ 314 $ 1,628 Capital expenditures included in accounts payable $ 289 $ 1,477 Expand Non-GAAP adjustments: Stock-based compensation and related payroll tax (4,084 ) (3,746 ) (9,730 ) (7,264 ) Acquisition-related expense (210 ) — (554 ) — Amortization of purchased intangible assets (99 ) — (152 ) — One-time legal expense (721 ) (71 ) (1,247 ) (71 ) Tax planning expense (150 ) (400 ) (150 ) (400 ) Non-GAAP total operating expenses $ 39,136 $ 35,925 $ 76,484 $ 74,425 Expand Three Months Ended June 30, Six Months Ended June 30, GAAP income from operations $ 10,311 $ 7,916 $ 19,089 $ 15,129 GAAP operating margin 14.9 % 13.2 % 14.1 % 12.5 % Non-GAAP adjustments: Stock-based compensation and related payroll tax 4,586 4,309 10,878 8,298 Acquisition-related expense 210 — 554 — Amortization of purchased intangible assets 380 — 583 — One-time legal expense 721 71 1,247 71 Tax planning expense 150 400 150 400 Non-GAAP operating income $ 16,358 $ 12,696 $ 32,501 $ 23,898 Non-GAAP operating margin 23.6 % 21.1 % 24.0 % 19.8 % Expand Three Months Ended June 30, Six Months Ended June 30, GAAP net income $ 10,538 $ 9,476 $ 20,081 $ 19,202 GAAP net income margin 15.2 % 15.8 % 14.8 % 15.9 % Exclude: Interest and other income, net (1,618 ) (3,067 ) (3,318 ) (7,074 ) Exclude: Depreciation and amortization 3,681 2,815 7,280 5,507 Exclude: Provision for income taxes 1,391 1,507 2,326 3,001 EBITDA 13,992 10,731 26,369 20,636 Exclude: Stock-based compensation and related payroll tax 4,586 4,309 10,878 8,298 Exclude: Acquisition-related expense 210 — 554 — Exclude: One-time legal expense 721 71 1,247 71 Exclude: Tax planning expense 150 400 150 400 Adjusted EBITDA $ 19,659 $ 15,511 $ 39,198 $ 29,405 Adjusted EBITDA margin 28.3 % 25.8 % 28.9 % 24.3 % Expand
Business Journals
a day ago
- Business Journals
Medicare Advantage offers better access, superior outcomes at a lower cost
More than half of people who are eligible for Medicare now choose Medicare Advantage plans because of the stable, affordable benefits and the quality, coordinated care these plans enable. [1] What's more, satisfaction among Medicare Advantage enrollees is exceptionally high, with 95% of MA beneficiaries satisfied with their health care coverage. [2] This successful program delivers real value to people while driving improvements in health quality and patient outcomes. Ultimately, the move from fee-for-service to value-based care, championed by Medicare Advantage, is a paradigm shift for a health system that historically pays for volume, not value. It has ushered in a new way of thinking about early detection and disease prevention. This shift directly challenges the status quo, which has relied on treating a constant influx of sick patients and is burdened with misaligned financial incentives. But UnitedHealthcare sees a different way forward — one that cares for patients before they are too sick for viable treatment and provides higher-quality care at a lower cost. Medicare Advantage drives affordability for plan members and helps reduce costs for the broader health system, with supporting data including: People enrolled in Medicare Advantage plans have saved 45% on premiums and out-of-pocket costs each year, which translates to an average savings of $2,200 annually compared to those in fee-for-service (FFS) Medicare. [3] In 2024, 75% of Medicare Advantage plans with Part D coverage, including those in UnitedHealthcare plans, paid no monthly premium. [4] Medicare Advantage beneficiaries are hospitalized less frequently, with a 43% lower rate of avoidable hospitalizations for any condition. [2] People with three or more chronic conditions who are enrolled in a Medicare Advantage saved over $2,500 annually. [5] [2] About Medicare Advantage, Better Medicare Alliance Disclaimer Plans are insured through UnitedHealthcare Insurance Company or one of its affiliated companies, a Medicare Advantage organization with a Medicare contract. Enrollment in the plan depends on the plan's contract renewal with Medicare.
